Reinhard Dummer
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.
Latzka J, Assaf C, Bagot M, Cozzio A, Dummer R, Guenova-Hötzenecker E, Gniadecki R, Hodak E, Jonak C, Klemke C, Knobler R, Morrris S, Nicolay J, Ortiz-Romero P, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer M, Wehkamp U, Whittaker S, Willemze R, Trautinger F. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023. Eur J Cancer 2023; 195:113343.
18.09.2023EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.
18.09.2023Eur J Cancer 2023; 195:113343
Latzka Johanna, Assaf Chalid, Bagot Martine, Cozzio Antonio, Dummer Reinhard, Guenova-Hötzenecker Emmanuella, Gniadecki Robert, Hodak Emmilia, Jonak Constanze, Klemke Claus-Detlev, Knobler Robert, Morrris Stephen, Nicolay Jan P, Ortiz-Romero Pablo L, Papadavid Evangelia, Pimpinelli Nicola, Quaglino Pietro, Ranki Annamari, Scarisbrick Julia, Stadler Rudolf, Väkevä Liisa, Vermeer Maarten H, Wehkamp Ulrike, Whittaker Sean, Willemze Rein, Trautinger Franz
EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.
Amaral T, Pop O, Chatziioannou E, Sinnberg T, Niessner H, Zhao J, Ring S, Jörger M, Schroeder C, Armeanu-Ebinger S, Cozzio A, Leiter U, Thomas I, Jochum W, Garbe C, Forchhammer S, Levesque M, Mangana J, Hölzel M, Dummer R, Schürch C, Forschner A, Flatz L. EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy. J Am Acad Dermatol 2023; 89:1072-1074.
22.07.2023EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.
22.07.2023J Am Acad Dermatol 2023; 89:1072-1074
Amaral Teresa, Pop Oltin Tiberiu, Chatziioannou Eftychia, Sinnberg Tobias, Niessner Heike, Zhao Jing Hua, Ring Sandra Stephanie, Jörger Markus, Schroeder Christopher, Armeanu-Ebinger Sorin, Cozzio Antonio, Leiter Ulrike, Thomas Ioannis, Jochum Wolfram, Garbe Claus, Forchhammer Stephan, Levesque Mitchell Paul, Mangana Joanna, Hölzel Michael, Dummer Reinhard, Schürch Christian M, Forschner Andrea, Flatz Lukas
The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres.
Troesch A, Hoellwerth M, Forchhammer S, Del Regno L, Lodde G, Turko P, Cheng F, Levesque M, Hadaschik E, Livingstone E, Peris K, Flatz L, Koelblinger P, Dummer R, Dimitriou F. The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres. J Eur Acad Dermatol Venereol 2023; 37:922-931.
03.03.2023The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres.
03.03.2023J Eur Acad Dermatol Venereol 2023; 37:922-931
Troesch Alexander, Hoellwerth Magdalena, Forchhammer Stephan, Del Regno Laura, Lodde Georg, Turko Patrick, Cheng Fei, Levesque Mitchell L, Hadaschik Eva, Livingstone Elisabeth, Peris Ketty, Flatz Lukas, Koelblinger Peter, Dummer Reinhard, Dimitriou Florentia
Swiss Recommendations for Cutaneous Basal Cell Carcinoma.
Ramelyte E, Nägeli M, Hunger R, Merat R, Gaide O, Navarini A, Cozzio A, Wagner N, Maul L, Dummer R. Swiss Recommendations for Cutaneous Basal Cell Carcinoma. Dermatology 2022; 239:1-10.
22.09.2022Swiss Recommendations for Cutaneous Basal Cell Carcinoma.
22.09.2022Dermatology 2022; 239:1-10
Ramelyte Egle, Nägeli Mirjam, Hunger Robert, Merat Rastine, Gaide Olivier, Navarini Alexander A, Cozzio Antonio, Wagner Nikolaus, Maul Lara Valeska, Dummer Reinhard
Maximal surgical tumour load reduction in immune-checkpoint inhibitor naïve patients with melanoma brain metastases correlates with prolonged survival.
Voglis S, Schaller V, Müller T, Gönel M, Winklhofer S, Mangana J, Dummer R, Serra C, Weller M, Regli L, Le Rhun E, Neidert M. Maximal surgical tumour load reduction in immune-checkpoint inhibitor naïve patients with melanoma brain metastases correlates with prolonged survival. Eur J Cancer 2022; 175:158-168.
17.09.2022Maximal surgical tumour load reduction in immune-checkpoint inhibitor naïve patients with melanoma brain metastases correlates with prolonged survival.
17.09.2022Eur J Cancer 2022; 175:158-168
Voglis Stefanos, Schaller Valentina, Müller Timothy, Gönel Meltem, Winklhofer Sebastian, Mangana Joana, Dummer Reinhard, Serra Carlo, Weller Michael, Regli Luca, Le Rhun Emilie, Neidert Marian C
Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown.
Kostner L, Cerminara S, Pamplona G, Maul J, Dummer R, Ramelyte E, Mangana J, Wagner N, Cozzio A, Kreiter S, Kogler A, Streit M, Wysocki A, Zippelius A, Läubli H, Navarini A, Maul L. Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown. Cancers (Basel) 2022; 14
10.05.2022Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown.
10.05.2022Cancers (Basel) 2022; 14
Kostner Lisa, Cerminara Sara Elisa, Pamplona Gustavo Santo Pedro, Maul Julia-Tatjana, Dummer Reinhard, Ramelyte Egle, Mangana Johanna, Wagner Nikolaus, Cozzio Antonio, Kreiter Saskia, Kogler Angelika, Streit Markus, Wysocki Anja, Zippelius Alfred, Läubli Heinz, Navarini Alexander, Maul Lara Valeska
Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Zehnder M, Amarov B, Abrunhosa-Branquinho A, Maiwald-Urosevic M, Mühleisen B, Saulite I, Anzengruber F, Imhof L, Navarini A, Cozzio A, Dummer R, Dimitriou F, Guenova E. Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type. Dermatology 2022; 238:967-976.
14.02.2022Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
14.02.2022Dermatology 2022; 238:967-976
Zehnder Mara, Amarov Boyko, Abrunhosa-Branquinho André N, Maiwald-Urosevic Mirjana, Mühleisen Beda, Saulite Ieva, Anzengruber Florian, Imhof Laurence, Navarini Alexander A, Cozzio Antonio, Dummer Reinhard, Dimitriou Florentia, Guenova Emmanuella
Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome
Maredia H, Cozzio A, Dummer R, Ramelyte E, Kim E, Rozati S. Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome. JAAD Case Rep 2021; 15:92-96.
21.07.2021Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome
21.07.2021JAAD Case Rep 2021; 15:92-96
Maredia Hasina, Cozzio Antonio, Dummer Reinhard, Ramelyte Egle, Kim Ellen J, Rozati Sima
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Schaule J, Lohaus F, Abbasi-Senger N, Henke G, Szuecs M, Geier M, Sundahl N, Buergy D, Dummer R, Eckert F, Adebahr S, Schymalla M, Kroeze S, Blanck O, Stera S, Kahl K, Roeder F, Combs S, Kaul D, Claes A, Guckenberger M. Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score. Radiat Oncol 2020; 15:280.
14.12.2020Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
14.12.2020Radiat Oncol 2020; 15:280
Schaule Jana, Lohaus Fabian, Abbasi-Senger Nasrin, Henke Guido, Szuecs Marcella, Geier Michael, Sundahl Nora, Buergy Daniel, Dummer Reinhard, Eckert Franziska, Adebahr Sonja, Schymalla Markus M, Kroeze Stephanie G C, Blanck Oliver, Stera Susanne, Kahl Klaus H, Roeder Falk, Combs Stephanie E, Kaul David, Claes An, Guckenberger Matthias
Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis
Dimitriou F, Cozzio A, Dummer R, French L, Hoetzenecker W, Brüggen M, Kimeswenger S, Nair G, Schanz U, Guenova E. Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis. Front Med (Lausanne) 2020; 7:290.
25.06.2020Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis
25.06.2020Front Med (Lausanne) 2020; 7:290
Dimitriou Florentia, Cozzio Antonio, Dummer Reinhard, French Lars E, Hoetzenecker Wolfram, Brüggen Marie-Charlotte, Kimeswenger Susanne, Nair Gayathri, Schanz Urs, Guenova Emmanuella
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Schaule J, Lohaus F, Abbasi-Senger N, Henke G, Szuecs M, Geier M, Sundahl N, Buergy D, Dummer R, Eckert F, Adebahr S, Schymalla M, Kroeze S, Blanck O, Stera S, Kahl K, Roeder F, Combs S, Kaul D, Claes A, Guckenberger M. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score. Radiat Oncol 2020; 15:135.
01.06.2020Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
01.06.2020Radiat Oncol 2020; 15:135
Schaule Jana, Lohaus Fabian, Abbasi-Senger Nasrin, Henke Guido, Szuecs Marcella, Geier Michael, Sundahl Nora, Buergy Daniel, Dummer Reinhard, Eckert Franziska, Adebahr Sonja, Schymalla Markus M, Kroeze Stephanie G C, Blanck Oliver, Stera Susanne, Kahl Klaus H, Roeder Falk, Combs Stephanie E, Kaul David, Claes An, Guckenberger Matthias
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
Saulite I, Bobrowicz M, Hoetzenecker W, Pascolo S, Scarisbrick J, Dummer R, Cozzio A, Nägeli M, Anzengruber F, Varypataki E, Dimitriou F, Fassnacht C, Chang Y, Desislava I, Guenova E. Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation. Oncoimmunology 2020; 9:1738797.
18.03.2020Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
18.03.2020Oncoimmunology 2020; 9:1738797
Saulite Ieva, Bobrowicz Malgorzata, Hoetzenecker Wolfram, Pascolo Steve, Scarisbrick Julia, Dummer Reinhard, Cozzio Antonio, Nägeli Mirjam, Anzengruber Florian, Varypataki Eleni, Dimitriou Florentia, Fassnacht Christina, Chang Yun-Tsan, Desislava Ignatova, Guenova Emmanuella
Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study
Brüggen M, Schlaak M, Nguyen V, Romani N, Cozzio A, Nair G, Dimitriou F, French L, Dummer R, Guenova E, Wehkamp U, Nicolay J, Valencak J, Stranzenbach R, Li N, Stadler R, Jonak C, Bauer W, Porkert S, Blaschke A, Meiß F, working group for cutaneous lymphoma of the Arbeitsgemeinschaft Dermatologische Forschung (ADF). Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study. J Eur Acad Dermatol Venereol 2020
19.01.2020Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study
19.01.2020J Eur Acad Dermatol Venereol 2020
Brüggen Marie-Charlotte, Schlaak Max, Nguyen Van Anh, Romani Nikolaus, Cozzio Antonio, Nair Gayathri, Dimitriou Florentia, French Lars, Dummer Reinhard, Guenova Emmanuella, Wehkamp Ulrike, Nicolay Jan, Valencak Julia, Stranzenbach René, Li Nick, Stadler Rudolf, Jonak Constanze, Bauer Wolfgang, Porkert Stefanie, Blaschke Amelie, Meiß Frank, working group for cutaneous lymphoma of the Arbeitsgemeinschaft Dermatologische Forschung (ADF)
Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2 mutated extramammary Paget's disease.
Nordmann T, Messerli-Odermatt O, Meier L, Micaletto S, Coppetti T, Nägeli M, Kamarachev J, Kudura K, Freiberger S, Rordorf T, Mangana J, Braun R, Dummer R. Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2 mutated extramammary Paget's disease. Oncotarget 2019; 10:6647-6650.
19.11.2019Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2 mutated extramammary Paget's disease.
19.11.2019Oncotarget 2019; 10:6647-6650
Nordmann Thierry M, Messerli-Odermatt Olivia, Meier Larissa, Micaletto Sara, Coppetti Thomas, Nägeli Mirjam, Kamarachev Jivko, Kudura Ken, Freiberger Sandra N, Rordorf Tamara, Mangana Joanna, Braun Ralph, Dummer Reinhard
Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment
Diem S, Risch M, Recher M, Risch L, Dummer R, Levesque M, Mangana J, Hillmann D, Niederer R, Berner F, Ali O, Bomze D, Fässler M, Flatz L. Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment. J Immunother 2019; 42:89-93.
01.04.2019Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment
01.04.2019J Immunother 2019; 42:89-93
Diem Stefan, Risch Martin, Recher Mike, Risch Lorenz, Dummer Reinhard, Levesque Mitchell P, Mangana Joanna, Hillmann Dorothea, Niederer Rebekka, Berner Fiamma, Ali Omar Hasan, Bomze David, Fässler Mirjam, Flatz Lukas
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
Fässler M, Jörger M, Recher M, Risch L, Güsewell S, Risch M, Speiser D, Ludewig B, Levesque M, Dummer R, Siano M, Krolik M, Diem S, Mangana J, Hasan Ali O, Berner F, Bomze D, Ring S, Niederer R, Gil Cruz C, Pérez Shibayama C, Flatz L. Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients. J Immunother Cancer 2019; 7:50.
20.02.2019Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
20.02.2019J Immunother Cancer 2019; 7:50
Fässler Mirjam, Jörger Markus, Recher Mike, Risch Lorenz, Güsewell Sabine, Risch Martin, Speiser Daniel E, Ludewig Burkhard, Levesque Mitchell P, Dummer Reinhard, Siano Marco, Krolik Michal, Diem Stefan, Mangana Joanna, Hasan Ali Omar, Berner Fiamma, Bomze David, Ring Sandra, Niederer Rebekka, Gil Cruz Cristina, Pérez Shibayama Christian Ivan, Flatz Lukas
Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation
Hartwig T, Schlapbach C, Conrad C, Flatz L, Dummer R, Navarini A, Cheng P, Yawalkar N, Schreiner B, Zwicky P, Becher B. Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation. Cell Rep 2018; 25:3564-3572.e4.
26.12.2018Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation
26.12.2018Cell Rep 2018; 25:3564-3572.e4
Hartwig Tom, Schlapbach Christoph, Conrad Curdin, Flatz Lukas, Dummer Reinhard, Navarini Alexander, Cheng Phil, Yawalkar Nikhil, Schreiner Bettina, Zwicky Pascale, Becher Burkhard
Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study
Brüggen M, French L, Hoetzenecker W, Cozzio A, Dummer R, Desislava I, Chang Y, Schanz U, Haralambieva E, Kerl K, Guenova E. Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study. Acta Derm Venereol 2018; 98:835-841.
10.10.2018Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study
10.10.2018Acta Derm Venereol 2018; 98:835-841
Brüggen Marie-Charlotte, French Lars E, Hoetzenecker Wolfram, Cozzio Antonio, Dummer Reinhard, Desislava Ignatova, Chang Yun-Tsan, Schanz Urs, Haralambieva Eugenia, Kerl Katrin, Guenova Emmanuella
Diagnostic value of F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site
Wolpert F, Preusser M, Kaufmann P, Reyns N, Roth P, Frauenfelder T, Dummer R, Stahel R, Stupp R, Neidert M, Regli L, Andratschke N, Leske H, Petyt G, Füreder L, Rushing E, Berghoff A, Weller M, Le Rhun E. Diagnostic value of F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site. Eur J Cancer 2018; 96:64-72.
17.04.2018Diagnostic value of F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site
17.04.2018Eur J Cancer 2018; 96:64-72
Wolpert Fabian, Preusser Matthias, Kaufmann Philipp Antonio, Reyns Nicolas, Roth Patrick, Frauenfelder Thomas, Dummer Reinhard, Stahel Rolf, Stupp Roger, Neidert Marian Christoph, Regli Luca, Andratschke Nicolaus, Leske Henning, Petyt Gregory, Füreder Lisa Michaela, Rushing Elisabeth, Berghoff Anna Sophie, Weller Michael, Le Rhun Emilie
Evaluation of the National Swiss Skin Cancer Screening Campaign 2013: Do We Do the Right Thing?
Braun R, French L, Hafner J, Dummer R, Merat R, Arnold A, Gaide O, Hunger R, Ulrich K, Cozzio A. Evaluation of the National Swiss Skin Cancer Screening Campaign 2013: Do We Do the Right Thing?. Dermatology (Basel) 2017
14.12.2017Evaluation of the National Swiss Skin Cancer Screening Campaign 2013: Do We Do the Right Thing?
14.12.2017Dermatology (Basel) 2017
Braun Ralph-Peter, French Lars E, Hafner Jürg, Dummer Reinhard, Merat Rastine, Arnold Andreas, Gaide Olivier, Hunger Robert, Ulrich Karina, Cozzio Antonio